PCRX - Pacira BioSciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
1.62B
Enterprise Value 3
1.68B
Trailing P/E
210.00
Forward P/E 1
18.15
PEG Ratio (5 yr expected) 1
0.70
Price/Sales (ttm)
4.34
Price/Book (mrq)
4.73
Enterprise Value/Revenue 3
4.50
Enterprise Value/EBITDA 6
38.74

Trading Information

Stock Price History

Beta (3Y Monthly) 0.59
52-Week Change 3-16.46%
S&P500 52-Week Change 38.78%
52 Week High 355.00
52 Week Low 334.64
50-Day Moving Average 337.69
200-Day Moving Average 340.89

Share Statistics

Avg Vol (3 month) 3787.22k
Avg Vol (10 day) 3531.74k
Shares Outstanding 541.64M
Float 41.4M
% Held by Insiders 10.68%
% Held by Institutions 1103.57%
Shares Short (Sep 30, 2019) 43.5M
Short Ratio (Sep 30, 2019) 43.06
Short % of Float (Sep 30, 2019) 48.72%
Short % of Shares Outstanding (Sep 30, 2019) 48.42%
Shares Short (prior month Aug 30, 2019) 42.75M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 2.04%
Operating Margin (ttm)7.68%

Management Effectiveness

Return on Assets (ttm)2.50%
Return on Equity (ttm)2.41%

Income Statement

Revenue (ttm)372.48M
Revenue Per Share (ttm)9.04
Quarterly Revenue Growth (yoy)22.00%
Gross Profit (ttm)194.74M
EBITDA 43.27M
Net Income Avi to Common (ttm)7.6M
Diluted EPS (ttm)0.19
Quarterly Earnings Growth (yoy)6.50%

Balance Sheet

Total Cash (mrq)292.24M
Total Cash Per Share (mrq)7.02
Total Debt (mrq)343.4M
Total Debt/Equity (mrq)100.51
Current Ratio (mrq)4.75
Book Value Per Share (mrq)8.21

Cash Flow Statement

Operating Cash Flow (ttm)64.11M
Levered Free Cash Flow (ttm)61.05M